Cannabis industry hits back: pain management claims are putting patients at risk by Martin Lane March 24, 2021April 26, 2024 New advice to GPs from the Australian and New Zealand College of Anaesthetists (ANZCA) on prescribing […]
Pain organisations express doubts over efficacy of medicinal cannabis by Martin Lane March 23, 2021April 26, 2024
‘Reputation arrives on foot, and leaves on horseback’: industry urged not to rush to profitability by Steve Jones March 18, 2021April 26, 2024
Chief scientist calls on MCIA to draw up research strategy to tackle ‘uniquely Australian challenges’ by Steve Jones March 18, 2021April 26, 2024
CSIRO to support local industry and drive development of cannabis therapeutics under new licence by Martin Lane February 26, 2021April 26, 2024
Cert III and IV medicinal cannabis cultivation and production courses now available by Martin Lane February 16, 2021April 26, 2024
Pharmacies overwhelmed: ‘Every second customer is asking for CBD’ by Martin Lane February 4, 2021April 26, 2024
Industry reacts to TGA down-scheduling decision with cautious optimism by Martin Lane December 17, 2020April 26, 2024
Is Pete Evans the man we want to represent medicinal cannabis? by Martin Lane December 2, 2020April 26, 2024
TGA weighs further advice ahead of down-scheduling decision by Martin Lane November 30, 2020April 26, 2024
